NeuroBo Pharmaceuticals Total Assets

NeuroBo Pharmaceuticals (NRBO) currently reports a total assets of $14M as of March 2026. That compares with $12M in the prior-year period — up 18.6% year over year. Use the charts on this page to explore NeuroBo Pharmaceuticals's total assets history and peer comparisons.

NeuroBo Pharmaceuticals's total assets increased from $12M to $14M — a 18.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroBo Pharmaceuticals reported $14M in total assets as of March 2026. That compares with $12M in the prior-year period — up 18.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroBo Pharmaceuticals, and consider following NRBO for alerts when major investors trade the stock.

NeuroBo Pharmaceuticals is classified in the Healthcare sector. On total assets, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NRBO with unrelated industries.